Literature DB >> 15047798

Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model.

Machiko Nomura1, Takashi Ohashi, Keiko Nishikawa, Hironori Nishitsuji, Kiyoshi Kurihara, Atsuhiko Hasegawa, Rika A Furuta, Jun-ichi Fujisawa, Yuetsu Tanaka, Shino Hanabuchi, Nanae Harashima, Takao Masuda, Mari Kannagi.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL). Although the viral transactivation factor, Tax, has been known to have apparent transforming ability, the exact function of Tax in ATL development is still not clear. To understand the role of Tax in ATL development, we introduced short-interfering RNAs (siRNAs) against Tax in a rat HTLV-1-infected T-cell line. Our results demonstrated that expression of siRNA targeting Tax successfully downregulated Tax expression. Repression of Tax expression was associated with resistance of the HTLV-1-infected T cells to Tax-specific cytotoxic-T-lymphocyte killing. This may be due to the direct effect of decreased Tax expression, because the Tax siRNA did not alter the expression of MHC-I, CD80, or CD86. Furthermore, T cells with Tax downregulation appeared to lose the ability to develop tumors in T-cell-deficient nude rats, in which the parental HTLV-1-infected cells induce ATL-like lymphoproliferative disease. These results indicated the importance of Tax both for activating host immune response against the virus and for maintaining the growth ability of infected cells in vivo. Our results provide insights into the mechanisms how the host immune system can survey and inhibit the growth of HTLV-1-infected cells during the long latent period before the onset of ATL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047798      PMCID: PMC374260          DOI: 10.1128/jvi.78.8.3827-3836.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia.

Authors:  T Kinoshita; A Tsujimoto; K Shimotohno
Journal:  Int J Cancer       Date:  1991-02-20       Impact factor: 7.396

2.  Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family.

Authors:  M Seiki; A Hikikoshi; T Taniguchi; M Yoshida
Journal:  Science       Date:  1985-06-28       Impact factor: 47.728

3.  Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.

Authors:  S Tamiya; M Matsuoka; K Etoh; T Watanabe; S Kamihira; K Yamaguchi; K Takatsuki
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

4.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

5.  Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting.

Authors:  M Yoshida; M Osame; K Usuku; M Matsumoto; A Igata
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

6.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

7.  Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells.

Authors:  T Ohashi; S Hanabuchi; H Kato; Y Koya; F Takemura; K Hirokawa; T Yoshiki; Y Tanaka; M Fujii; M Kannagi
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.

Authors:  M Kannagi; K Sugamura; H Sato; K Okochi; H Uchino; Y Hinuma
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax.

Authors:  S Niewiesk; S Daenke; C E Parker; G Taylor; J Weber; S Nightingale; C R Bangham
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1.

Authors:  J Inoue; M Seiki; T Taniguchi; S Tsuru; M Yoshida
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  15 in total

Review 1.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

Review 3.  Human T cell lymphotropic virus-associated leukemia/lymphoma.

Authors:  Lee Ratner
Journal:  Curr Opin Oncol       Date:  2005-09       Impact factor: 3.645

4.  Simian T Lymphotropic Virus 1 Infection of Papio anubis: tax Sequence Heterogeneity and T Cell Recognition.

Authors:  James M Termini; Diogo M Magnani; Helen S Maxwell; William Lauer; Iris Castro; Jerilyn Pecotte; Glen N Barber; David I Watkins; Ronald C Desrosiers
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

5.  Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.

Authors:  Rashade A H Haynes; Evan Ware; Christopher Premanandan; Bevin Zimmerman; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

6.  Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.

Authors:  Shuichi Kinpara; Atsuhiko Hasegawa; Atae Utsunomiya; Hironori Nishitsuji; Hiroyuki Furukawa; Takao Masuda; Mari Kannagi
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

7.  Enhanced replication of human T-cell leukemia virus type 1 in T cells from transgenic rats expressing human CRM1 that is regulated in a natural manner.

Authors:  Ryo Takayanagi; Takashi Ohashi; Eizaburo Yamashita; Yohei Kurosaki; Kumiko Tanaka; Yoshiyuki Hakata; Yasumasa Komoda; Satoru Ikeda; Yasuko Tsunetsugu-Yokota; Yuetsu Tanaka; Hisatoshi Shida
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

8.  Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.

Authors:  Stefan Niewiesk
Journal:  ILAR J       Date:  2016

9.  Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.

Authors:  Dustin C Edwards; Katherine M McKinnon; Claudio Fenizia; Kyung-Jin Jung; John N Brady; Cynthia A Pise-Masison
Journal:  Viruses       Date:  2011-10-10       Impact factor: 5.048

10.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.